* Healthequity Inc HQY.OQ HQY.O is expected to show a
rise in
quarterly revenue when it reports results on September 3 for
the period ending July 31 2024
* The Draper Utah-based company is expected to report a
17.0% increase in revenue to $284.87 million from $243.55
million a year ago, according to the mean estimate from 12
analysts, based on LSEG data.
* LSEG's mean analyst estimate for Healthequity Inc is for
earnings of 70 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 14 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for
Healthequity Inc
is $105.00, above its last closing price of $77.09.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Apr. 30 2024 0.65 0.66 0.80 Beat 21.7
Jan. 31 2024 0.59 0.56 0.63 Beat 11.6
Oct. 31 2023 0.50 0.50 0.60 Beat 20
Jul. 31 2023 0.48 0.48 0.53 Beat 11
Jan. 0.41 0.41 0.50 Beat 23.2
1 0001
Jan. 31 2023 0.35 0.35 0.37 Beat 5.4
Oct. 31 2022 0.35 0.35 0.38 Beat 9.7
Jul. 31 2022 0.33 0.33 0.33 Met 0
This summary was machine generated August 30 at 20:06 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)